|
|
|
|
|
by varjag
1219 days ago
|
|
Practical neural networks operate in enormous parameter spaces that are impossible to meaningfully test for all possible adversarial inputs and degraded outputs. Your FSD could well recognize stop signs in your battery of tests but not when someone drew a squirrel on it with green sharpie. |
|
You make a black box test on several thousands (sometimes only hundreds) patients, and if patients who received the drug perform better the patients who received the placebo, then the drug is usually accepted for commercialization.
Yet one isolated patient may be subject to several comorbidities, her environment could be weird, she could ingest other drugs (or coffee, OTC vitamins or even pomelo) without having declared it. In a recent past women were not part of clinical trials because being pregnant makes them very "non-standard'.